Drug intelligence / Profile preview

Gene-modified SQ-SHED (Spinal Cord Injury)

Development stage: Preclinical
Lead developer: Kidswell Bio
Modality: Gene Therapies, Stem Cell Therapies → Cell Therapies
Administration: Intrathecal

Overview

Gene-modified SQ-SHED (Spinal Cord Injury) is an experimental gene-modified cell therapy being developed by Kidswell Bio (formerly Gene Techno Science) and its subsidiary, S-Quatre Corporation, in collaboration with Nagoya University. The therapy utilizes the SQ-SHED platform, which consists of high-quality Stem cells from Human Exfoliated Deciduous teeth (SHED). In this specific program, the SHED cells are genetically modified with an undisclosed gene, referred to as 'Gene X', to enhance their therapeutic potential for treating spinal cord injury. The program is currently in the preclinical stage, aiming to leverage the regenerative and neuroprotective properties of modified stem cells to repair neural damage.

Other names: Spinal Cord Injury program (Gene X)Gene-modified SQ-SHED for Spinal Cord Injury

Beyond the preview

Go deeper on Gene-modified SQ-SHED (Spinal Cord Injury).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gene-modified SQ-SHED (Spinal Cord Injury).

Explore the full profile